Literature DB >> 31531036

Disposition kinetics of orbifloxacin in tissues of crucian carp (Carassius auratus) following a single intramuscular administration.

Y R Yang1, F Yang2, N Sun3, G Y Wang2.   

Abstract

BACKGROUND: Orbifloxacin is being widely used in China to treat fish infections in an extra-label manner, which may cause its potential residues in edible tissues. AIMS: The purpose of this study was to determine the disposition kinetics of orbifloxacin in crucian carp (Carassius auratus) following intramuscular administration for its further safe application in aquaculture industry.
METHODS: Tissue samples of skin, muscle, kidney, and liver were collected from six crucian carps reared at 25°C at 5, 10, 15, 30, 45 min, 1, 2, 4, 6, 12, 24, 48, 72, and 96 h following a single intramuscular injection at 7.5 mg/kg body weight (BW). The orbifloxacin concentrations in tissues were determined using a high-performance liquid chromatography (HPLC) method with a fluorescence detector, then average concentrations versus time data were subjected to non-compartmental analysis to obtain the kinetic parameters.
RESULTS: The peak concentration of 5.68 ± 0.03 µg/g was calculated in kidney at 2 h, followed by muscle (5.51 ± 0.01 µg/g) at 4 h, liver (4.84 ± 0.20 µg/g) at 2 h, and skin (4.27 ± 0.08 µg/g) at 4 h. Area under concentration-time curve was calculated as 79.22, 94.72, 118.65, and 129.02 h·µg/g in kidney, liver, skin, and muscle, respectively. And the elimination half-lives were determined as 18.17, 18.41, 18.77, and 19.11 h in skin, kidney, muscle, and liver, respectively.
CONCLUSION: It was shown that orbifloxacin was well distributed into tissues while relatively slowly eliminated in crucian carp reared at 25°C following a single intramuscular injection.

Entities:  

Keywords:  Crucian carp; Disposition kinetics; Intramuscular injection; Orbifloxacin; Tissue depletion

Year:  2019        PMID: 31531036      PMCID: PMC6716280     

Source DB:  PubMed          Journal:  Iran J Vet Res        ISSN: 2252-0589            Impact factor:   1.376


  22 in total

Review 1.  Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals.

Authors:  Marilyn Martinez; Patrick McDermott; Robert Walker
Journal:  Vet J       Date:  2005-09-09       Impact factor: 2.688

2.  Pharmacokinetics and milk distribution characteristics of orbifloxacin following intravenous and intramuscular injection in lactating ewes.

Authors:  A Goudah; H-J Cho; H-C Shin; J-H Shim; N L Regmi; M Shimoda; A M Abd El-Aty
Journal:  J Vet Pharmacol Ther       Date:  2009-08       Impact factor: 1.786

3.  Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares.

Authors:  G R Haines; M P Brown; R R Gronwall; K A Merritt; L K Baltzley
Journal:  Can J Vet Res       Date:  2001-07       Impact factor: 1.310

4.  Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.

Authors:  Patricia A Kay-Mugford; Allan J Weingarten; Maureen Ngoh; Robert Zolynas; Amy White; Terry Katz; Robert Simmons; Kanwal J Varma
Journal:  Vet Ther       Date:  2002

5.  Long depletion time of enrofloxacin in rainbow trout (Oncorhynchus mykiss).

Authors:  Dario Lucchetti; Laura Fabrizi; Emilio Guandalini; Elisabetta Podestà; Luigi Marvasi; Anna Zaghini; Ettore Coni
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

7.  Approaches for application of sub and supercritical fluid extraction for quantification of orbifloxacin from plasma and milk: application to disposition kinetics.

Authors:  A M Abd El-Aty; Jeong-Heui Choi; Ma-Wou Ko; Sathya Khay; Ayman Goudah; Ho-Chul Shin; Jin-Suk Kim; Byung-Joon Chang; Chi-Ho Lee; Jae-Han Shim
Journal:  Anal Chim Acta       Date:  2008-10-19       Impact factor: 6.558

8.  Pharmacokinetics and milk penetration of orbifloxacin after intravenous and intramuscular injections to dromedary lactating camels (Camelus dromedaries).

Authors:  A Goudah; K Abo-El-Sooud
Journal:  J Vet Pharmacol Ther       Date:  2008-06       Impact factor: 1.786

9.  Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats.

Authors:  P Marín; E Escudero; E Fernández-Varón; C M Cárceles
Journal:  J Dairy Sci       Date:  2007-09       Impact factor: 4.034

10.  Depletion study and estimation of the withdrawal period for enrofloxacin in pacu (Piaractus mesopotamicus).

Authors:  J A R Paschoal; S P Quesada; L U Gonçalves; J E P Cyrino; F G R Reyes
Journal:  J Vet Pharmacol Ther       Date:  2013-03-07       Impact factor: 1.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.